Physician

Anjana Myneni, M.D.

According to 2025 Medicare claims, Anjana Myneni, M.D. (NPI: 1316063274) practices endocrinology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is GRUNBERGER DIABETES MEDICAL CENTER, PC (NPI: 1215154497; TIN: 37-1417837) and primary practice location at 48302-5052. Myneni is affiliated with the Senior Health Connect ACO 9 (ACO ID: A5387) and Complete Care Collaborative of the South (ACO ID: D0335), participating under both the MSSP and REACH models.

Myneni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 162 traditional Medicare patients, billed 1,232 HCPCS/CPT codes, and received $56,126 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,724 prescription claims across 306 beneficiaries totaling $1,821,259 in drug costs, led by Ozempic (Semaglutide). DME data shows 388 claims. Open Payments data shows 112 records totaling $2,458. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,002,394 to $1,821,259. For DME billing, reported payments moved sharply higher in recent years, from $7,572 to $112,602.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	298	1,805	$74,367
2016	243	1,365	$51,273
2017	252	1,904	$72,908
2018	213	1,535	$61,749
2019	214	1,454	$58,542
2020	170	1,187	$48,490
2021	165	1,110	$56,949
2022	168	1,212	$56,246
2023	170	1,200	$54,257
2024	162	1,232	$56,126

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	316	2,358	$1,002,394
2016	314	2,321	$997,838
2017	314	2,500	$1,312,029
2018	311	2,318	$1,354,407
2019	311	2,278	$1,355,905
2020	296	2,252	$1,239,001
2021	296	2,408	$1,422,462
2022	294	2,339	$1,543,845
2023	302	2,429	$1,791,589
2024	306	2,724	$1,821,259

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	311	608	$17,831
2016	303	620	$23,732
2017	269	512	$31,958
2018	238	518	$32,245
2019	214	513	$54,070
2020	146	446	$41,876
2021	121	436	$47,007
2022	109	509	$67,468
2023	121	536	$80,310
2024	124	388	$108,482

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	130	348	$92
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	58	166	$26
83036	Hemoglobin a1c level	97	296	$9
82044	Urine microalbumin (protein) analysis	39	41	$6
82947	Blood glucose (sugar) level	60	145	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	186	10,600	$333,522
Trulicity	Dulaglutide	152	8,456	$274,192
Jardiance	Empagliflozin	198	12,953	$239,065
Mounjaro	Tirzepatide	110	4,732	$169,598
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	59	5,423	$97,939

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	60	239	$98,788
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	13	13	$2,940
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	12	$2,674
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	14	$1,864
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	31	60	$1,465

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	112	$2,458	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anjana Myneni, M.D.?

Tedicare shows public-source Medicare data for Anjana Myneni, M.D. (NPI 1316063274), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anjana Myneni, M.D. have ACO affiliation data?

Anjana Myneni, M.D. is shown with ACO affiliation data for Senior Health Connect ACO 9 (MSSP, ACO ID A5387) and Complete Care Collaborative of the South (REACH, ACO ID D0335).

What billing organization is linked to Anjana Myneni, M.D.?

Anjana Myneni, M.D. is linked to GRUNBERGER DIABETES MEDICAL CENTER, PC (billing NPI 1215154497) in the available physician profile data.

Does Anjana Myneni, M.D. have Open Payments data?

Anjana Myneni, M.D. has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.